Pakistan approves Russia's Sputnik V COVID-19 vaccine for emergency use

News Image

By MG News | February 10, 2021 at 09:58 AM GMT+05:00

0:00

February 10, 2021: Russia's Sputnik V has become the third COVID-19 vaccine to be approved by Pakistan for emergency use after China's Sinopharm and the one developed by AstraZeneca and Oxford University, the country's health minister said on Tuesday.

"Sputnik has received EUA (emergency use authorization)," the minister, Faisal Sultan, told Reuters in a text message.

Pakistan has become the 22nd country to approve Sputnik V, the Russian Direct Investment Fund, responsible for marketing the vaccine abroad, said.

It is to be administered in two shots, three weeks apart has a six-month shelf life, and is stored at -18 Celsius, according to a document on the vaccine's authorization.

The authorization to M/s AGP Ltd, Karachi, is valid until April 1, 2021, the document said, adding it was for immunization of those aged 18 and over.

A fourth vaccine candidate, developed by CanSino Biologics Inc (CanSinoBIO), has also completed clinical trials in the South Asian nation of 220 million people, showing 65.7% efficacy in symptomatic cases and a 90.98% success rate in severe cases in an interim analysis of global trials, Sultan said on Monday.

He said its efficacy in the Pakistani subset at preventing symptomatic cases was 74.8%. It was 100% for preventing severe disease.

CanSinoBio's single-dose regimen and normal refrigerator storage requirement could make it a favorable option for many countries.

AJ Pharma led CanSinoBIO's trial to import the vaccine vials initially before filling them in Pakistan, the first company to do so locally.

Sultan said Pakistan could get shots "in the range of tens of millions" under an agreement with the Chinese firm.

Pakistan has launched its vaccination drive with 500,000 doses of Sinopharm donated by longtime ally China, giving shots to frontline health workers as a priority.

Pakistan has also secured 17 million doses of the AstraZeneca vaccine under a global scheme to deliver coronavirus treatments to developing nations.

Reuters

Related News

Name Price/Vol %Chg/NChg
KSE100 125,627.31
258.99M
1.00%
1248.25
ALLSHR 78,584.71
1,142.41M
1.16%
904.89
KSE30 38,153.79
69.25M
0.63%
238.06
KMI30 184,886.50
91.38M
0.01%
13.72
KMIALLSHR 53,763.81
554.57M
0.54%
290.61
BKTi 31,921.68
33.15M
1.78%
557.94
OGTi 27,773.98
9.65M
-0.40%
-112.21
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 107,935.00 107,955.00
107,505.00
-300.00
-0.28%
BRENT CRUDE 66.59 66.63
66.49
-0.15
-0.22%
RICHARDS BAY COAL MONTHLY 97.00 97.00
97.00
1.05
1.09%
ROTTERDAM COAL MONTHLY 107.65 107.65
105.85
1.25
1.17%
USD RBD PALM OLEIN 998.50 998.50
998.50
0.00
0.00%
CRUDE OIL - WTI 64.94 65.02
64.83
-0.17
-0.26%
SUGAR #11 WORLD 16.19 16.74
16.14
-0.52
-3.11%

Chart of the Day


Latest News
July 01, 2025 at 06:00 AM GMT+05:00

MG Morning Breeze: Updates to Skim before Market


June 30, 2025 at 11:55 PM GMT+05:00

TRG: Dominos Tumbling for the Management



Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg